A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 350
Comprehensive Pages
- 40
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022
The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
5/20/2022
BreakingGlaucomaLaserRegulation
Belkin’s Automated, Contactless Laser for Glaucoma Gains CE Marking
Israel’s Belkin Vision announced May 16 that its Eagle automated laser treatment for glaucoma received CE marking. The Eagle is the first contactless laser for glaucoma. Controlled rollout of the s...
5/20/2022
BreakingRegulationRetina
UK is First in Europe to Approve Teva’s Lucentis Biosimilar Ongavia
Israel’s Teva Pharmaceutical Industries announced May 17 that the UK’s Medicines & Healthcare Regulatory Agency (MHRA) had granted marketing approval to Ongavia, a Lucentis (ranibizumab) biosimilar...
5/20/2022
BreakingDealsDiagnostic
Visionix to Distribute Righton Products in Europe, the Americas, and Select Asia Pacific Countries
Visionix, formerly Luneau Technology, and Japan’s Right MFG announced May 16 that they had entered a long-term strategic partnership agreement. Financial terms of the deal were not disclosed. Visio...
5/20/2022
BreakingDealsGlaucomaPharma
Skye to Acquire Emerald in Stock Deal, List on Canadian Securities Exchange
Cannabis companies Skye Bioscience and Emerald Health Therapeutics announced May 12 that they had signed a deal for Skye to acquire all shares of Emerald in a share-for-share transaction that inclu...
5/20/2022
BreakingClinical TrialCornealDry Eye
Brim Partners with Ora for Phase III Trial of Dry Eye Candidate
Brim Biotechnology, of Taiwan, announced May 17 that it had partnered with ophthalmic research company Ora on a Phase III clinical trial, set to begin in Q4-2022, for Brim’s lead drug candidate, BR...
5/20/2022
BreakingCataractClinical TrialPharma
Formosa, AimMax See Positive Results in Phase III Trial of Post-cataract Inflammation, Pain Candidate
Formosa Pharmaceuticals and AimMax Therapeutics reported positive results May 12 from the first of two pivotal Phase III studies of APP13007, a novel ophthalmic nanosuspension of the corticosteroid...
5/20/2022
BreakingCataractGlaucomaIndustryPharma
Visiox Pharma Appoints Ryan S. Bleeks as Chief Executive Officer
Visiox Pharma, which is advancing new formulations of well-known ophthalmic compounds, announced May 17 that it had appointed Ryan S. Bleeks as chief executive officer. Previously, Bleeks was vice ...
5/13/2022
BreakingDealsPresbyopia
Zhaoke Licenses Visus’ Presbyopia Drop Candidates for Greater China, South Korea, Select Southeast Asian Markets
Visus Therapeutics announced May 11 that Hong Kong’s Zhaoke Ophthalmology had signed an exclusive licensing agreement for the development and commercialization of presbyopia drop candidates Brimoch...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.